MARGARET NESMITH: Open Payments
NPI 1093067795 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 25 payments from 13 companies in 2025. Trend: 2023 $663 · 2024 $583 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $137 |
| GENZYME CORPORATION | 2 | $64 |
| Celgene Corporation | 2 | $59 |
| SOBI, INC | 2 | $56 |
| PFIZER INC. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Agios Pharmaceuticals, Inc. | 1 | $34 |
| Blueprint Medicines Corporation | 1 | $30 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
Products named: AYVAKIT, MONJUVI, REBLOZYL, Vonjo, ELIQUIS, JAKAFI, OJJAARA, Fabhalta.
Industry payments across TX — which companies pay providers there.
